Search - tctmd.com

Displaying 1 - 20 of 102

Sort: Relevancy | Date

Presentation THT 2026

Translational Validation of the SEPRDD (Sensing Pressure Releasing Diuretic Drug) - Heart Failure Device : Bridging Bench to Large Animal Models for Heart Failure Therapy

Presenter: Vasim Panwar

March 03, 2026

Presentation THT 2026

Who is the Ideal Candidate for Device-Based Therapy for ADHF

Presenter: James E. Udelson

March 03, 2026

Presentation TCT 2025

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

Presenter: Azeem Latib

October 28, 2025

Presentation TCT 2025

TCT 973: A Systematic Review and Meta-analysis of Intra-Aortic Balloon Pump compared with Medical Therapy alone or with Left-Ventricular Assist Device for Cardiogenic Shock

Presenter: Aleena Usman

October 27, 2025

Presentation TCT 2025

Patient-Specific Diagnostic, Monitoring & Predictive Devices for Structural Heart Healthcare (Prognics)

Presenter: Mohammad Sarraf

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

Presenter: Sheldon E. Litwin

October 25, 2025

Presentation TCT 2025

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

Presenter: Daniel Burkhoff

October 25, 2025

Presentation TCT 2025

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

Presenter: Michal Kosowski

October 25, 2025

Presentation THT 2025

Baroceptor Activation Therapy

Presenter: Shelley Hall

February 12, 2025

Presentation THT 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Presenter: Beth Davison

February 12, 2025

Presentation THT Abstracts 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 11, 2025

Presentation TCT 2024

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Presenter: Eric Rytkin

October 29, 2024

Presentation NY Valves 2024

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Presenter: Torsten P. Vahl

June 07, 2024

Presentation Miami Valves 2024

Update on Device Therapy for Heart Failure

Presenter: Luanda Grazette

February 03, 2024

Presentation Miami Valves 2024

Update on Device Therapy for Heart Failure

Presenter: Luanda Grazette

February 03, 2024

Presentation TCT 2023

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Presenter: Clyde Yancy

October 24, 2023

Presentation THT 2023

MIRTH: Myocardial Intramural Remodeling by Transvenous Tether

Presenter: Adam Greenbaum

March 21, 2023

Advertisement

Translational Validation of the SEPRDD (Sensing Pressure Releasing Diuretic Drug) - Heart Failure Device : Bridging Bench to Large Animal Models for Heart Failure Therapy

Who is the Ideal Candidate for Device-Based Therapy for ADHF

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

TCT 973: A Systematic Review and Meta-analysis of Intra-Aortic Balloon Pump compared with Medical Therapy alone or with Left-Ventricular Assist Device for Cardiogenic Shock

Patient-Specific Diagnostic, Monitoring & Predictive Devices for Structural Heart Healthcare (Prognics)

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

Baroceptor Activation Therapy

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Update on Device Therapy for Heart Failure

Update on Device Therapy for Heart Failure

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

MIRTH: Myocardial Intramural Remodeling by Transvenous Tether

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content